Oncotelic Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Oncotelic Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.3M, a 2966% decline year-over-year.
  • Oncotelic Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$4.66M, a 62.6% increase year-over-year.
  • Oncotelic Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.9M, a 255% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $5.09M.
  • Oncotelic Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$9.39M, a 1.17% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$4.66M -$3.3M -$3.42M -2966% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$1.24M -$210K +$6.55M +96.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$7.79M -$409K +$117K +22.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$7.9M -$736K +$4.55M +86.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-12
Q3 2023 -$12.5M $115K +$893K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$13.3M -$6.76M -$22.8M -142% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $9.42M -$525K +$4.32M +89.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $5.09M -$5.29M -$3.5M -195% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-12
Q3 2022 $8.59M -$778K +$785K +50.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $7.81M $16M +$19.2M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-18
Q1 2022 -$11.4M -$4.85M -$2.05M -73% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$9.39M -$1.79M +$1.65M +47.8% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-04-20
Q3 2021 -$11M -$1.56M +$424K +21.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-18
Q2 2021 -$11.5M -$3.23M -$3.81M -655% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$7.65M -$2.8M +$1.85M +39.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$9.5M -$3.44M +$41.5K +1.19% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$9.54M -$1.99M -$995K -100% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$8.55M $582K +$1.77M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-20
Q1 2020 -$10.3M -$4.66M -$3.68M -377% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$6.64M -$3.48M -$3.33M -2152% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$3.31M -$991K -$777K -363% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$2.53M -$1.19M -$1.04M -676% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$1.5M -$976K -$785K -412% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$713K -$155K +$2.28M +93.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-14
Q3 2018 -$2.99M -$214K +$3.32M +93.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$6.31M -$153K +$3.73M +96.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-19
Q1 2018 -$10M -$191K +$3.77M +95.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-19
Q4 2017 -$13.8M -$2.43M +$1.02M +29.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-10
Q3 2017 -$14.8M -$3.54M -$300K -9.27% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$14.5M -$3.88M -$243K -6.67% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$14.3M -$3.96M -$633K -19% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$13.7M -$3.45M +$514K +13% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$14.2M -$3.24M +$356K +9.91% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$14.5M -$3.64M -$317K -9.54% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$14.2M -$3.33M -$553K -19.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$13.7M -$3.97M -$1.33M -50.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$12.3M -$3.59M -$142K -4.12% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$12.2M -$3.32M +$605K +15.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$12.8M -$2.77M -$142K -5.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$12.6M -$2.64M -$541K -25.8% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$12.1M -$3.45M -$804K -30.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$11.3M -$3.93M -$2.28M -138% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$9.03M -$2.63M -$750K -39.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$8.28M -$2.1M -$422K -25.2% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$7.86M -$2.65M -$399K -17.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$7.46M -$1.65M +$612K +27% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$8.07M -$1.88M +$11K +0.58% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$8.08M -$1.68M +$670K +28.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-30
Q3 2012 -$8.75M -$2.25M +$1.27M +36% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$10M -$2.27M +$666K +22.7% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-10-18
Q1 2012 -$10.7M -$1.89M -$1.03M -119% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$9.65M -$2.35M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-20
Q3 2011 -$3.51M +$10M +74% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$2.93M -$5.47M -216% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$863K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$13.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $2.54M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.